Recently-Appointed InVivo Therapeutics Acting CFO Sean Moran Abruptly Resigns

Sean Moran, recently-appointed acting CFO of InVivo Therapeutics Holdings, resigned effective immediately, and interim CEO Michael Astrue will fill the position until a replacement is found, according to a Boston Business Journal report. Mr. Moran was the company's director of finance who took the position of acting CFO at the end of August when former CEO and CFO Francis Reynolds resigned.

The executive shake-up comes at nearly the same time that the company announced approval of its biopolymer scaffolding for acute spinal cord injuries will take years longer than anticipated.

On Tuesday, InVivo also cancelled its presentation at the 15th Annual Rodman and Renshaw Healthcare Conference in New York City.

More Articles on Devices:
Titan Spine Debuts Study Supporting its Device Surface Technology
Medical Device Company DFINE Names Greg Barrett as President, CEO
NuVasive Spine Foundation Raises $230k for Improving Care of Global Patients in Need